Oxford BioDynamics Plc (AIM:OBD)
London · Delayed Price · Currency is GBP · Price in GBX 0.4850
-0.0150 (-3.00%)
Jul 28, 2025, 4:35 PM GMT+1
Oxford BioDynamics Employees
Oxford BioDynamics had 51 employees as of September 30, 2024. The number of employees increased by 6 or 13.33% compared to the previous year.
Employees
51
Change (1Y)
6
Growth (1Y)
13.33%
Revenue / Employee
20.36K GBP
Profits / Employee
-286.20K GBP
Market Cap
9.79M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 51 | 6 | 13.33% |
| Sep 30, 2023 | 45 | 1 | 2.27% |
| Sep 30, 2022 | 44 | 5 | 12.82% |
| Sep 30, 2021 | 39 | 2 | 5.41% |
| Sep 30, 2020 | 37 | 6 | 19.35% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Oxford Nanopore Technologies | 1,382 |
Oxford BioDynamics News
- 13 days ago - AIM Market Roundup: Oxford Biodynamics, GCM Resources, ECO Animal Health - The Armchair Trader
- 6 months ago - AIM Market Roundup: Marechale, Oxford Biodynamics, SDX Energy - The Armchair Trader
- 8 months ago - Small Cap Stocks: i-nexus Global, Genip, Oxford Biodynamics - The Armchair Trader
- 8 months ago - Three Quick Facts: Oxford Biodynamics, Entain, Computacenter - The Armchair Trader
- 8 months ago - Small Cap Stocks: Brand Architekts, tinybuild, Quadrise - The Armchair Trader
- 8 months ago - Small Cap Stocks: Rockfire Resources, Fusion Antibodies, Oracle Power - The Armchair Trader
- 9 months ago - Small Cap Stocks: Empyrean, Seascape, Mirriad - The Armchair Trader
- 10 months ago - Oxford Biodynamics shares plummet as company faces cliff edge - The Armchair Trader